VEGFA and retinopathy of prematurity: A small retrospective study suggests that dexamethasone eye drops (0.1%) prior to peak neovessel formation (Type 2 ROP) before potential laser therapy markedly inhibits progression to severe neovascularization (Type 1 ROP) and decreases the need for laser or anti-VEGF treatment [17] aligned with the findings of our small prospective pilot study in extremely preterm infants at very high risk for severe ROP.